Neely J, Sabbagh SE, Dvergsten J, Madubata C, Berthier CC, Zheng Z, Goudsmit C, Matossian S, Ferris SP, Fragiadakis GK, Sirota M, Kahlenberg JM, Kim H, Turnier JL, CARRA Registry Investigators and CARRA Translational Medicine for Juvenile Myositis Working Group. Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype. Ann Rheum Dis. 2025 Nov;84(11):1836-1851 PMID: 40915939 SCOPUS ID: 2-s2.0-105015351461 09/08/2025
Coss SL, Sabbagh SE, Kim H. Updates in juvenile dermatomyositis: pathogenesis and therapy. Curr Opin Rheumatol. 2025 Nov 01;37(6):445-456 PMID: 40693918 SCOPUS ID: 2-s2.0-105011663978 07/23/2025
Chen KL, Chiu YE, Vleugels RA, Co DO, Kim H, Sabbagh SE, Arkin LM. Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies. J Invest Dermatol. 2025 Jun;145(6):1294-1304 PMID: 39530954 SCOPUS ID: 2-s2.0-85208676459 11/13/2024
Sabbagh SE, Haribhai D, Gershan JA, Verbsky J, Nocton J, Yassai M, Naumova EN, Hammelev E, Dasgupta M, Yan K, Gorski J, Williams CB. Corrigendum: Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination. Front Immunol. 2024;15:1446946 PMID: 38962010 PMCID: PMC11220386 SCOPUS ID: 2-s2.0-85197728513 07/04/2024
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C, Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup. Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539 PMID: 38937134 SCOPUS ID: 2-s2.0-85201290324 06/28/2024
Sabbagh SE, Haribhai D, Gershan JA, Verbsky J, Nocton J, Yassai M, Naumova EN, Hammelev E, Dasgupta M, Yan K, Gorski J, Williams CB. Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination. Front Immunol. 2024;15:1306490 PMID: 38873594 PMCID: PMC11169902 SCOPUS ID: 2-s2.0-85195642328 06/14/2024
Venerito V, Fornaro M, Sabbagh S, Ghosh S, Chinoy H, Gupta L, MyoLLM Investigators. Integrating large language models in medicine: a study of Claude 2\'s performance in MDAAT scoring for idiopathic inflammatory myopathies. Rheumatology (Oxford). 2024 Oct 01;63(10):e292-e293 PMID: 38648744 SCOPUS ID: 2-s2.0-85205524825 04/23/2024
Sabbagh SE, Verbsky JW. Interferonopathies Nelson Textbook of Pediatrics Volume 1 2. 1 January 2024:1530-1535.e1 SCOPUS ID: 2-s2.0-85206224972 01/01/2024
Karasawa R, Yudoh K, Sato T, Tanaka M, Sabbagh SE, Flegel WA, Mammen AL, Jarvis JN, Rider LG, Childhood Myositis Heterogeneity Study Group. Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis. Rheumatology (Oxford). 2023 Nov 02;62(11):3757-3762 PMID: 37144941 PMCID: PMC10629777 SCOPUS ID: 2-s2.0-85176496767 05/05/2023
Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI226-SI234 PMID: 35961028 PMCID: PMC9949705 SCOPUS ID: 2-s2.0-85160024916 08/13/2022